These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1576049)

  • 1. Prostaglandin I2 and the nitric oxide donor molsidomine have synergistic effects on thromboresistance in man.
    Sinzinger H; Rauscha F; O'Grady J; Fitscha P
    Br J Clin Pharmacol; 1992 Mar; 33(3):289-92. PubMed ID: 1576049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Synergism of PGI2 and molsidomine in arterial occlusive disease].
    Sinzinger H
    Z Kardiol; 1991; 80 Suppl 5():51-3. PubMed ID: 1776336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostacyclin and molsidomine synergise in their fibrinolytic and anti-platelet actions in patients with peripheral arterial disease.
    Bieroń K; Grodzińska L; Kostka-Trabka E; Gryglewski RJ
    Wien Klin Wochenschr; 1993; 105(1):7-11. PubMed ID: 8438599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molsidomine, a coronary drug with platelet-aggregating inhibitory activity].
    Silberbauer K; Slany J; Sinzinger H; Punzengruber C
    Z Kardiol; 1982 Aug; 71(8):539-43. PubMed ID: 6753382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of exogenous nitric oxide on smooth muscle cell proliferation following porcine carotid angioplasty.
    Groves PH; Banning AP; Penny WJ; Newby AC; Cheadle HA; Lewis MJ
    Cardiovasc Res; 1995 Jul; 30(1):87-96. PubMed ID: 7553728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibition of platelet functions by molsidomine in animals].
    Just M; Martorana PA; Nitz RE
    Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):226-8. PubMed ID: 3550643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between prostacyclin and molsidomine in blood cells and plasma.
    Gryglewski RJ; Bieroń K; Dembińska-Kieć A; Kostka-Trabka E; Zembowicz A
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21B():655-8. PubMed ID: 1825393
    [No Abstract]   [Full Text] [Related]  

  • 8. The long-term exposure of endothelial cells to molsidomine increases their antithrombogenicity by inducing the production of nitric oxide-related chemical substances.
    Berenger-Bahuet FP; Rolland PH
    J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S98-105. PubMed ID: 2484710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antithrombotic effects of molsidomine alone and in combination with other antithrombotic agents in a thrombosis model of the microcirculation of the rat].
    Giedrojc J; Weichert W; Breddin HK
    Z Kardiol; 1991; 80 Suppl 5():35-9. PubMed ID: 1663678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide-mediated cyclooxygenase activation. A key event in the antiplatelet effects of nitrovasodilators.
    Salvemini D; Currie MG; Mollace V
    J Clin Invest; 1996 Jun; 97(11):2562-8. PubMed ID: 8647949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No effect of highly dosed nitric oxide donor molsidomine on the angiographic restenosis rate after percutaneous coronary angioplasty: a randomized, placebo controlled, double-blind trial.
    Wöhrle J; Höher M; Nusser T; Hombach V; Kochs M
    Can J Cardiol; 2003 Apr; 19(5):495-500. PubMed ID: 12717484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the nitric oxide donor molsidomine on the early stages of liver damage in rats with bile duct ligation: a biochemical and immunohistochemical approach.
    Oztürk H; Yağmur Y; Buyukbayram H; Dokucu AI; Gurel A
    Eur Surg Res; 2002; 34(4):285-90. PubMed ID: 12145554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostacyclin (epoprostenol) as the sole antithrombotic agent in postdilutional hemofiltration.
    Canaud B; Mion C; Arujo A; N'Guyen QV; Paleyrac G; Hemmendinger S; Cazenave JP
    Nephron; 1988; 48(3):206-12. PubMed ID: 2965311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of molsidomine and free radical scavengers on the pulmonary thromboembolism in mice.
    Dikshit M; Seth P; Srimal RC
    Thromb Res; 1993 May; 70(4):317-27. PubMed ID: 8332961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of molsidomine and its metabolite SIN-1 on coronary vessel tone, platelet aggregation, and eicosanoid formation in vitro--inhibition of 12-HPETE biosynthesis.
    Darius H; Ahland B; Rücker W; Klaus W; Peskar BA; Schrör K
    J Cardiovasc Pharmacol; 1984; 6(1):115-21. PubMed ID: 6199592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of synergistic effect of molsidomine and sildenafil on development of pulmonary hypertension in chronic hypoxic rats.
    Andersen CU; Mulvany MJ; Simonsen U
    Eur J Pharmacol; 2005 Mar; 510(1-2):87-96. PubMed ID: 15740728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inhibition of the formation of platelet thrombus by molsidomine and SIN-1 in the mesenteric vessels rats].
    Breddin HK; Weichert W
    Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):223-5. PubMed ID: 3550642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide as a regulator of prostacyclin synthesis in cultured rat heart endothelial cells.
    Sievi E; Lähteenmäki TA; Alanko J; Vuorinen P; Vapaatalo H
    Arzneimittelforschung; 1997 Oct; 47(10):1093-8. PubMed ID: 9368700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of combinations of a prostacyclin analogue (Cicaprost) with different antithrombotic agents in a rat microcirculatory thrombosis model.
    Giedrojc J; Breddin HK
    Int J Microcirc Clin Exp; 1992 Aug; 11(3):277-86. PubMed ID: 1324230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molsidomine, a nitric oxide donor and L-arginine protects against rhabdomyolysis-induced myoglobinuric acute renal failure.
    Chander V; Chopra K
    Biochim Biophys Acta; 2005 May; 1723(1-3):208-14. PubMed ID: 15777642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.